AC
| |
ACUTA CAPITAL PARTNERS, LLC13F | |
| ACUTA CAPITAL PARTNERS, LLC | |
| Last update 2025-05-15 | 34 Stocks (6 new) |
| Value $86.00 Mil | Turnover 25 % |
ACUTA CAPITAL PARTNERS, LLC Top Holdings of 2025-03-31
View Full List
| Ticker | | Company | Shares | Value ($1000) | Shares Change % | Weighting % | Trade Impact % | % of Shares outstanding | 3M Change % | YTD Change % | Market Cap $Mil | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
OCUL | Ocular Therapeutix Inc | 1,219,724 | 8,940.6 | +9.78% | 10.370 | +0.92% | 0.770 | +54.99% | +32.67% | 1,804.9 | Biotechnology | |
INSM | Insmed Inc | 106,074 | 8,092.4 | +1.22% | 9.380 | +0.11% | 0.060 | +41.16% | +48.54% | 19,480.5 | Biotechnology | |
TRML | Tourmaline Bio Inc | 426,882 | 6,492.9 | +21.33% | 7.530 | +1.32% | 1.660 | +15.43% | -8.88% | 474.7 | Biotechnology | |
WHWK | Whitehawk Therapeutics Inc | 3,410,402 | 6,070.5 | +84.41% | 7.040 | +3.22% | 7.240 | +14.65% | -42.95% | 84.8 | Biotechnology | |
ELVN | Enliven Therapeutics Inc | 265,269 | 5,220.5 | 0% | 6.050 | 0% | 0.540 | +37.08% | +0.71% | 1,336.7 | Biotechnology | |
TRVI | Trevi Therapeutics Inc | 785,961 | 4,943.7 | +1.81% | 5.730 | +0.10% | 0.770 | +13.01% | +66.50% | 835.2 | Biotechnology | |
SLNO | Soleno Therapeutics Inc | 67,136 | 4,796.9 | New Holding | 5.560 | +5.56% | 0.130 | +24.61% | +93.99% | 4,599.5 | Biotechnology | |
ARGX | argenx SE | 7,023 | 4,156.7 | +1.64% | 4.820 | +0.08% | 0.010 | -5.30% | -8.20% | 34,972.3 | Biotechnology | |
ASND | Ascendis Pharma AS | 23,340 | 3,637.8 | +1.58% | 4.220 | +0.07% | 0.040 | +2.94% | +23.41% | 10,277.3 | Biotechnology | |
PRAX | Praxis Precision Medicines Inc | 87,141 | 3,300.0 | +29.10% | 3.830 | +0.86% | 0.430 | +59.37% | -30.03% | 1,096.9 | Biotechnology |
ACUTA CAPITAL PARTNERS, LLC's Historical Top Holdings Breakdowns
ACUTA CAPITAL PARTNERS, LLC's Top Stock Picks
View Full List
| Ticker | | Company | Date | Action | Impact % | Price Range | Price | Price Change from Avrg% | Comment | Current Shares | Share Change |
|---|---|---|---|---|---|---|---|---|---|---|---|
CRNX | Crinetics Pharmaceuticals Inc | 2025-03-31 | Sold Out Sold Out | -6.32% | 32.3 ($37.35) 53.15 | $31.11 | -16.71% | Sold Out | 0 | -122,900 | |
SLNO | Soleno Therapeutics Inc | 2025-03-31 | New Buy New Buy | +5.56% | 42.54 ($48.69) 71.99 | $87.20 | 79.09% | New holding | 67,136 | 67,136 | |
PCVX | Vaxcyte Inc | 2025-03-31 | Sold Out Sold Out | -3.71% | 37.76 ($79.95) 92.13 | $36.21 | -54.71% | Sold Out | 0 | -45,000 | |
ELVN | Enliven Therapeutics Inc | 2025-03-31 | Reduce Reduce | -3.43% | 19.62 ($21.52) 24.43 | $22.66 | 5.30% | Reduce -56.69% | 115,805 | -151,563 | |
WHWK | Whitehawk Therapeutics Inc | 2025-03-31 | Add Add | +3.22% | 1.78 ($2.61) 3.73 | $1.80 | -31.03% | Add 84.41% | 3,410,402 | 1,561,000 | |
OCS | Oculis Holding AG | 2025-03-31 | New Buy New Buy | +2.76% | 16.93 ($20.5) 22.91 | $17.50 | -14.63% | New holding | 125,000 | 125,000 | |
MRK | Merck & Co Inc | 2025-03-31 | New Buy New Buy | +2.39% | 83.01 ($93.37) 101.02 | $79.96 | -14.36% | New holding | 22,994 | 22,994 | |
SRZN | Surrozen Inc | 2025-03-31 | New Buy New Buy | +2.30% | 9.7 ($11.62) 17.02 | $8.48 | -27.02% | New holding | 170,000 | 170,000 | |
RVMD | Revolution Medicines Inc | 2025-03-31 | Reduce Reduce | -1.98% | 35.36 ($40.59) 44.42 | $38.30 | -5.64% | Reduce -40.32% | 66,662 | -45,038 | |
CDTX | Cidara Therapeutics Inc | 2025-03-31 | Add Add | +1.78% | 17.85 ($22.21) 27.3 | $59.96 | 169.97% | Add 130.77% | 125,708 | 71,235 |
ACUTA CAPITAL PARTNERS, LLC Total Holding History ($B)
ACUTA CAPITAL PARTNERS, LLC's Asset Allocation
ACUTA CAPITAL PARTNERS, LLC Past Portfolios
| Portfolio Date | Number of Stocks | New Stocks | Total Value ($Mil) | Q/Q Turnover |
|---|---|---|---|---|
Top Ranked Articles
- 1
ACUTA CAPITAL PARTNERS, LLC's Hypothetical Growth since 2025-03-31
ACUTA CAPITAL PARTNERS, LLC's Yearly Returns
| Year | Portfolio % | % | Excess Gain % |
|---|
ACUTA CAPITAL PARTNERS, LLC's Holdings Heat Map
Size field:
ACUTA CAPITAL PARTNERS, LLC's Holdings Bubble Chart
ACUTA CAPITAL PARTNERS, LLC News
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers